Imuraya Group Company Limited operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imuraya Group Company Limited with three other
bakery and confectionary companies in Asia:
Ismail Industries Limited
sales of 30.19 billion Pakistan Rupees [US$194.40 million]
of which 77%
was Food Processing),
GlaxoSmithKline Consumer Healthcare Limited
(47.82 billion Indian Rupees [US$662.79 million]
of which 100%
was Nutrition), and
Nakamuraya Co., Ltd.
(38.74 billion Japanese Yen [US$356.06 million]
of which 76%
was Confectionery Business).
During the year ended March of 2019, sales at
Imuraya Group Company Limited were ¥45.11 billion (US$414.54 million).
a very small
increase of 0.1%
versus 2018, when the company's sales were ¥45.06 billion.
This was the fifth consecutive year of sales increases at Imuraya Group Company Limited
(and since 2014, sales have increased a total of 24%).
Sales of Seasonings Business saw an increase
that was more than double the company's growth rate: sales were up
6.4% in 2019, from
¥5.35 billion to ¥5.69 billion.
Imuraya Group Company Limited also saw significant increases in sales in
Other Businesses (up 3.8% to ¥237.41 million)
Not all segments of Imuraya Group Company Limited experienced an increase in sales in 2019:
sales of Distribution Business fell 0.8% to ¥39.18 billion.